✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Pfizer Ltd.

PFIZER

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹22,797 Cr.
P/E
27.16

Pfizer Ltd.

  • Pfizer
  • Astrazeneca Pharma I
  • Eris Lifesciences
  • TJI Pharma

FAQs on Pfizer Ltd. Shareprice

Pfizer has given lower returns compared to its competitors.
Pfizer has grown at ~-0.47% over the last 5yrs while peers have grown at a median rate of 14.91%

Pfizer is not expensive.
Latest PE of Pfizer is 27.25, while 3 year average PE is 35.77.
Also latest EV/EBITDA of Pfizer is 24.8 while 3yr average is 26.03.

View FAQ's On Business

Growth Table

  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Balance Sheet

  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Cash Flow

  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Quarterly Results

  • Pfizer Ltd.
  • Astrazeneca Pharma I
  • Eris Lifesciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Pfizer Ltd. Financials

Balance sheet of Pfizer is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Pfizer is increasing.
Latest net debt of Pfizer is -₹2,701.3 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹5,597.54 Crs.

Yes, profit is increasing.
The profit of Pfizer is ₹839 Crs for TTM, ₹768 Crs for Mar 2025 and ₹551 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pfizer latest dividend payout ratio is 98.34% and 3yr average dividend payout ratio is 59.57%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech